{"id":950291,"date":"2026-04-09T11:57:44","date_gmt":"2026-04-09T15:57:44","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/fate-therapeutics-to-participate-in-upcoming-second-quarter-2026-conferences\/"},"modified":"2026-04-09T11:57:44","modified_gmt":"2026-04-09T15:57:44","slug":"fate-therapeutics-to-participate-in-upcoming-second-quarter-2026-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/fate-therapeutics-to-participate-in-upcoming-second-quarter-2026-conferences\/","title":{"rendered":"Fate Therapeutics to Participate in Upcoming Second Quarter 2026 Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>SAN DIEGO, April  09, 2026  (GLOBE NEWSWIRE) &#8212; Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that management will participate in five upcoming investor conferences in the second quarter of 2026.<\/p>\n<p>\n        <strong>25<\/strong><br \/>\n        <sup><br \/>\n          <strong>th<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Needham Virtual Healthcare Conference<\/strong>\n      <\/p>\n<p>Location: Virtual<\/p>\n<p>Date: April 14<sup>th<\/sup>\u00a0\u00a0<\/p>\n<p>\n        <strong>Bank of America Healthcare Conference 2026<\/strong>\n      <\/p>\n<p>Location: Encore at the Wynn &#8211; Las Vegas, NV\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/p>\n<p>Date: May 13<sup>th<\/sup><\/p>\n<p>\n        <strong>H.C. Wainwright 4<\/strong><br \/>\n        <sup><br \/>\n          <strong>th<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual BioConnect Investor Conference\u00a0<\/strong>\n      <\/p>\n<p>Location: Nasdaq &#8211; New York, NY\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/p>\n<p>Date: May 19<sup>th<\/sup><\/p>\n<p>\n        <strong>2026 Jeffries Global Healthcare Conference<\/strong>\n      <\/p>\n<p>Location<strong>: <\/strong>Marriott Marquis &#8211; New York, NY<\/p>\n<p>Date: June 4<sup>th<\/sup><\/p>\n<p>\n        <strong>Goldman Sachs 47<\/strong><br \/>\n        <sup><br \/>\n          <strong>th<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Global Healthcare Conference<\/strong>\n      <\/p>\n<p>Location: Loews Miami Beach Hotel &#8211; Miami Beach, FL<\/p>\n<p>Date: June10<sup>th<\/sup><\/p>\n<p>The Company may participate in a presentation or a fireside chat at these conferences. When available, a live webcast will be accessible under \u201cEvents &amp; Presentations\u201d in the Investors section of the Company\u2019s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=b3T6Uy1wtPNiRnihIqzzcQRBVobenwovzetOEtJ5A9z_kvaGmGC_uGaF5Em2XtigADIlMI0M5jE9m3Hw0FwSqPy-ygtLCVJL23qz1uRJ9tOaMLQa3sU2EmmAew5iP8bmB2fmswbbXE61pCn3XxxwxCjP6nQ3bhFW-2d2WMxNpV1CJ423J8AR3Jx3wfm4I1gUvGvOjZrI8N6d0V-gUcWIIY410gz-rg5sx359HV9tZeo7IAVzqqhVOD1mwOBelFYUM9KcpttvcS-soTwr6tvK8GffpFMvrDNj1miPdQQ16MYWo0_H9tdQTYNhWp7UMPp6yQbUF0E7Tp3uIz8GncTNT-UNEDN71JhlLSz1f-iVubtznVagQ_qKxlHmD0muNSo7a8KmJfYiE2oKA5slT7-m6qUQufykbhbbMvlbfZFWwocOyE486mpV2-hKcm0S6N-Tdz74VjC6dbg030pemna1Vud0gUQQdpAj8Z9LJhk7K67NOlWo_-s-nP7Vs9NmpTc_QX3SSJxYCsWlruRMDIasEj7yAdzzBLkOrprQ2-AktI_HePm15zou891IHaoTkc0DzjHxQlaNk7JOlqkUdQrUCDUBYVrROSDMl9H2KfoOZ49tu3_8nz_6LgmOvF8NH8RSGdpnz9IyojpZSg3wFwhYOAzknNxXVnDhBGLpggktlH3RiL5-S4K-2PJOWZpd20dnPyun_QLdrxl-c4GJd8OXfS1-x-0kFLhyfq4KnmAEhBS9Z7uBvCa7YADiUxtQUo87_1Qbcrmhw8nLBVj8Z80PQMqmCrGYvjCCthOiMRUe18u-0njo9RUch95cBUuqE5qWUE7c7TkUBVK_xf3G-DOG0S6IXjWa60usvETkHY_V3G65wfbeSwi3zaJM6DiSHE7T\" rel=\"nofollow\" target=\"_blank\">www.fatetherapeutics.com<\/a>. An archived replay of the webcast will be available for 30 days on the Company\u2019s website following the event.<\/p>\n<p>\n        <strong>About Fate Therapeutics, Inc.<\/strong>\n      <\/p>\n<p>Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases. Using its proprietary iPSC product platform, the Company has established a leadership position in creating multiplexed-engineered master iPSC lines and in the manufacture and clinical development of off-the-shelf, iPSC-derived cell products. The Company\u2019s pipeline includes iPSC-derived T-cell and natural killer (NK) cell product candidates, which are selectively designed, incorporate novel synthetic controls of cell function, and are intended to deliver multiple therapeutic mechanisms to patients. Fate Therapeutics is headquartered in San Diego, CA. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=b3T6Uy1wtPNiRnihIqzzcQRBVobenwovzetOEtJ5A9wwhHVvOCLliHTSw1_qQxetlgBuhJDy2lDoMCqew-YrkEe39OhO29kHFJzkDydKsGdOcMkJMyabZsAVMKqXA_SCClR34O33Z3fJOoh_0Zj1ccURq7odEHUYmPISRxf0tGKshKqmd7ECPOWeimO8Zt_gY8ZKkmucqs4Dt0AsP055g7F21W6-jgzrG9FwWvtkEF1xn2K8PwBMyOOvD9i1D2Bt7yyfCZDHDtio8R6EIYDOBsLE1iwsmedIHwYU-YvAEQRanS1yBzrOSYBHtyue9YeQbfGvacyEXwq9j8t2dld65wPRXkz0vA9_rbymLflpPOwbh3IvgbTScnnplIJCxc1mRdAKRX9UUaYyknmiMw6tTH_H2gMTC0XX_1D7FEyN3db6tNilSpx3Ned0Pv0BNdwr8SXOdnhLGWsSWuLfA_-JbFXfZRwDwNUCAeiRQuf__aiwYa8LohULIF-rYC-sNcRy\" rel=\"nofollow\" target=\"_blank\">www.fatetherapeutics.com<\/a>.<\/p>\n<p>\n        <strong>Contact:<\/strong>\n      <\/p>\n<p>Ryan Douglas<br \/>Fate Therapeutics, Inc.<br \/>IR@fatetherapeutics.com<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4Njc2OCM3NTI3MTIyIzIwMDQyMDE=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NDg4MWY4NzktODkwNi00ZWMyLWEwMjEtY2JiODMyMGNiYjJmLTEwMTU3NzQtMjAyNi0wNC0wOS1lbg==\/tiny\/Fate-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, April 09, 2026 (GLOBE NEWSWIRE) &#8212; Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that management will participate in five upcoming investor conferences in the second quarter of 2026. 25 th Annual Needham Virtual Healthcare Conference Location: Virtual Date: April 14th\u00a0\u00a0 Bank of America Healthcare Conference 2026 Location: Encore at the Wynn &#8211; Las Vegas, NV\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Date: May 13th H.C. Wainwright 4 th Annual BioConnect Investor Conference\u00a0 Location: Nasdaq &#8211; New York, NY\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Date: May 19th 2026 Jeffries Global Healthcare Conference Location: Marriott Marquis &#8211; New York, NY Date: June 4th Goldman Sachs 47 &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/fate-therapeutics-to-participate-in-upcoming-second-quarter-2026-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Fate Therapeutics to Participate in Upcoming Second Quarter 2026 Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-950291","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Fate Therapeutics to Participate in Upcoming Second Quarter 2026 Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/fate-therapeutics-to-participate-in-upcoming-second-quarter-2026-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Fate Therapeutics to Participate in Upcoming Second Quarter 2026 Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, April 09, 2026 (GLOBE NEWSWIRE) &#8212; Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that management will participate in five upcoming investor conferences in the second quarter of 2026. 25 th Annual Needham Virtual Healthcare Conference Location: Virtual Date: April 14th\u00a0\u00a0 Bank of America Healthcare Conference 2026 Location: Encore at the Wynn &#8211; Las Vegas, NV\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Date: May 13th H.C. Wainwright 4 th Annual BioConnect Investor Conference\u00a0 Location: Nasdaq &#8211; New York, NY\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Date: May 19th 2026 Jeffries Global Healthcare Conference Location: Marriott Marquis &#8211; New York, NY Date: June 4th Goldman Sachs 47 &hellip; Continue reading &quot;Fate Therapeutics to Participate in Upcoming Second Quarter 2026 Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/fate-therapeutics-to-participate-in-upcoming-second-quarter-2026-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-09T15:57:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4Njc2OCM3NTI3MTIyIzIwMDQyMDE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fate-therapeutics-to-participate-in-upcoming-second-quarter-2026-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fate-therapeutics-to-participate-in-upcoming-second-quarter-2026-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Fate Therapeutics to Participate in Upcoming Second Quarter 2026 Conferences\",\"datePublished\":\"2026-04-09T15:57:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fate-therapeutics-to-participate-in-upcoming-second-quarter-2026-conferences\\\/\"},\"wordCount\":321,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fate-therapeutics-to-participate-in-upcoming-second-quarter-2026-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4Njc2OCM3NTI3MTIyIzIwMDQyMDE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fate-therapeutics-to-participate-in-upcoming-second-quarter-2026-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fate-therapeutics-to-participate-in-upcoming-second-quarter-2026-conferences\\\/\",\"name\":\"Fate Therapeutics to Participate in Upcoming Second Quarter 2026 Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fate-therapeutics-to-participate-in-upcoming-second-quarter-2026-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fate-therapeutics-to-participate-in-upcoming-second-quarter-2026-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4Njc2OCM3NTI3MTIyIzIwMDQyMDE=\",\"datePublished\":\"2026-04-09T15:57:44+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fate-therapeutics-to-participate-in-upcoming-second-quarter-2026-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fate-therapeutics-to-participate-in-upcoming-second-quarter-2026-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fate-therapeutics-to-participate-in-upcoming-second-quarter-2026-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4Njc2OCM3NTI3MTIyIzIwMDQyMDE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4Njc2OCM3NTI3MTIyIzIwMDQyMDE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fate-therapeutics-to-participate-in-upcoming-second-quarter-2026-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Fate Therapeutics to Participate in Upcoming Second Quarter 2026 Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Fate Therapeutics to Participate in Upcoming Second Quarter 2026 Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/fate-therapeutics-to-participate-in-upcoming-second-quarter-2026-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Fate Therapeutics to Participate in Upcoming Second Quarter 2026 Conferences - Market Newsdesk","og_description":"SAN DIEGO, April 09, 2026 (GLOBE NEWSWIRE) &#8212; Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that management will participate in five upcoming investor conferences in the second quarter of 2026. 25 th Annual Needham Virtual Healthcare Conference Location: Virtual Date: April 14th\u00a0\u00a0 Bank of America Healthcare Conference 2026 Location: Encore at the Wynn &#8211; Las Vegas, NV\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Date: May 13th H.C. Wainwright 4 th Annual BioConnect Investor Conference\u00a0 Location: Nasdaq &#8211; New York, NY\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Date: May 19th 2026 Jeffries Global Healthcare Conference Location: Marriott Marquis &#8211; New York, NY Date: June 4th Goldman Sachs 47 &hellip; Continue reading \"Fate Therapeutics to Participate in Upcoming Second Quarter 2026 Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/fate-therapeutics-to-participate-in-upcoming-second-quarter-2026-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2026-04-09T15:57:44+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4Njc2OCM3NTI3MTIyIzIwMDQyMDE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fate-therapeutics-to-participate-in-upcoming-second-quarter-2026-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fate-therapeutics-to-participate-in-upcoming-second-quarter-2026-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Fate Therapeutics to Participate in Upcoming Second Quarter 2026 Conferences","datePublished":"2026-04-09T15:57:44+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fate-therapeutics-to-participate-in-upcoming-second-quarter-2026-conferences\/"},"wordCount":321,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fate-therapeutics-to-participate-in-upcoming-second-quarter-2026-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4Njc2OCM3NTI3MTIyIzIwMDQyMDE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fate-therapeutics-to-participate-in-upcoming-second-quarter-2026-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/fate-therapeutics-to-participate-in-upcoming-second-quarter-2026-conferences\/","name":"Fate Therapeutics to Participate in Upcoming Second Quarter 2026 Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fate-therapeutics-to-participate-in-upcoming-second-quarter-2026-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fate-therapeutics-to-participate-in-upcoming-second-quarter-2026-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4Njc2OCM3NTI3MTIyIzIwMDQyMDE=","datePublished":"2026-04-09T15:57:44+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fate-therapeutics-to-participate-in-upcoming-second-quarter-2026-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/fate-therapeutics-to-participate-in-upcoming-second-quarter-2026-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fate-therapeutics-to-participate-in-upcoming-second-quarter-2026-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4Njc2OCM3NTI3MTIyIzIwMDQyMDE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4Njc2OCM3NTI3MTIyIzIwMDQyMDE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fate-therapeutics-to-participate-in-upcoming-second-quarter-2026-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Fate Therapeutics to Participate in Upcoming Second Quarter 2026 Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/950291","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=950291"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/950291\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=950291"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=950291"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=950291"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}